An immunological re-evaluation confirmed that her case fulfilled the 2009 NIH ALPS criteria, but with a significant reduction in immunoglobulin levels, and her plasma-soluble FAS ligand levels were normal. Here, FAS is linked to autoimmune lymphoproliferative syndrome.